Crunchbase profile is pretty weird. Says we were acquired

New Post Public Reply Private Reply Replies (0) Message Board
freegriff
288
Crunchbase profile is pretty weird. Says we were acquired by Avant in May 2016/ Obvi just talking about DX

https://www.crunchbase.com/organization/amara...es#/entity

Venture-Backed, Alumni
Amarantus Bioscience
Amarantus BioSciences is a development-stage, publicly-traded biotechnology company discovering & developing first-in-class treatments for diseases associated with the dysfunction of a wide range of biological pathways, beginning with apoptosis.

Neurodegenerative diseases such as Parkinson's, ALS and Alzheimer's as well as Cardiovascular Disease such as Myocardial Infarction, Angina, Coronary Artery Disease and Heart Failure are in dire need of treatments that address the region specific apoptosis associated with each disorder.

Amarantus BioSciences intends to advance therapies that will provide patients with safe and effective treatment options and help curb the soaring healthcare costs associated with care of chronic illnesses. The Company is currently focusing on the development of its lead drug candidate AMRS001 for Parkinson's Disease and Cardiac Ischemia.

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Binance's Strategic Shift: Changpeng Zhao's Influence and Future

Updated Category News Views 115

Binance's New Direction Under Changpeng Zhao In the dynamic world of cryptocurrency, Binance (CRYPTO: BNB) is at a pivotal moment as co-founder Changpeng Zhao steps back into the public eye after a presidential pardon. This development marks an important chapter for Binance as it reassesses its strategy within the U.S. market, a territory it once ruled. Zhao's Vision for...

Continue Reading
DarioHealth Prepares to Announce Q4 and Full Year Results

Updated Category News Views 104

DarioHealth Announces Upcoming Financial Results DarioHealth Corp. (NASDAQ: DRIO), a trailblazer in the digital health landscape, is gearing up to report its financial outcomes for the fourth quarter and full year 2024. The anticipated announcement is set to unfold prior to the market's opening on the forthcoming Monday. Details of the Conference Call Time and Access To...

Continue Reading
Luminit Inc. Expands Manufacturing to Elevate Holographic Film Production

Updated Category News Views 175

Luminit Inc. Expands U.S. Manufacturing Capacity Luminit Inc., known for its expertise in holographic optics, is making significant strides in expanding its manufacturing capabilities to meet the surging demand for mass production of Holographic Optical Elements (HOEs). This expansion reflects the company's commitment to the automotive, defense, and industrial sectors,...

Continue Reading
Projected Growth of Alternative Credentials in Higher Education

Updated Category News Views 173

Exploring the Rise of Alternative Credentials in Education In recent years, the education landscape has experienced significant transformations, particularly in how higher education institutions approach credentialing. Alternative credentials, such as micro-credentials and digital badges, are gaining traction in response to the widening skills gap and the shifting demands...

Continue Reading
enCore Energy Reports Significant Uranium Gains at Alta Mesa

Updated Category News Views 133

enCore Energy's Advances at Alta Mesa CPP enCore Energy (NASDAQ: EU) has achieved remarkable progress at the Alta Mesa In-Situ Recovery (ISR) Uranium Central Processing Plant (CPP). Recently, the company announced its most productive month since operations commenced, capturing over 50,000 pounds of uranium during the month. This achievement is particularly significant in...

Continue Reading